Motus gi announces 1-for-20 reverse stock split

Fort lauderdale, fla., july 25, 2022 (globe newswire) -- motus gi holdings, inc., (nasdaq: mots) ("motus gi" or the "company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that it will effect a 1-for-20 reverse stock split of its outstanding common stock. the company's common stock will begin trading on a split-adjusted basis at the opening of the market on tuesday, july 26, 2022. the company's common stock will continue to trade on the nasdaq capital market under the symbol “mots” and under the new cusip number, 62014p405.
MOTS Ratings Summary
MOTS Quant Ranking